Medical Systems - Adv Dev

Abstract

This Program Element (PE) funds development of medical materiel within the early system integration portion of the System Development and Demonstration phase of the acquisition life cycle using 6.4 (Advanced Component Development and Prototype) funding. Program efforts support transition of promising Science and Technology candidate medical technologies (drugs, vaccines, medical devices, diagnostics, and mechanisms for detection and control of disease carrying insects) to larger scale testing in humans for safety and effectiveness. Programs are aligned to meet future force requirements identified within concept documents and organizational structures. This PE also provides funding for Food and Drug Administration (FDA) regulated human clinical trials to gain additional information about safety and effectiveness on the path to licensure for use in humans. These efforts are managed by U.S. Army Medical Materiel Development Activity (USAMMDA) of the U.S. Army Medical Research and Development Command.

Document Details

• Document Type: R2 Budgetary Justification
• Publication Date: Oct 01, 2023
• Source ID: 0603807A_4_2040_PB_2023
• Change Summary Explanation: FY 2023 funding increase reflects the fact that the FY 2022 President's Budget request did not include out-year funding.
• Service Agency Name: Army

Entities

Organizations

• United States Army

Tags

DTIC Thesaurus Topics

• Acquired Immune Deficiency Syndrome
• Brain Injuries
• Combat Casualty Care
• Health Services
• Hiv Infections
• Hospitals
• Infection
• Infectious Diseases
• Life Cycles
• Medical Evacuation
• Medical Personnel
• Military Hospitals
• Military Medicine
• Organizational Structure
• Test And Evaluation
• Wound Infections
• Wounds And Injuries

Readers

• Infectious Disease/Epidemiology
• Instructional Design and Training Evaluation.
• Military Science and Technology Research and Modernization.

Technology Areas

• Biotechnology